Susquehanna Portfolio Strategies’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Susquehanna Portfolio Strategies's LMAT Position: Q2 2026 in Review
Susquehanna Portfolio Strategies increased its LeMaitre Vascular (LMAT) stake by 66% in Q2 2026, buying an estimated $1.65M and bringing the position to 40,393 shares worth $3.88M. The position accounts for 0.06% of the portfolio, ranked #332.
Susquehanna Portfolio Strategies first reported a position in LMAT in Q3 2024 and has held it in 4 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Susquehanna Portfolio Strategies held 40,393 shares of LeMaitre Vascular worth $3.88M as of Q2 2026.
- Susquehanna Portfolio Strategies bought 16,062 LeMaitre Vascular shares in Q2 2026, an estimated $1.65M.
- LeMaitre Vascular made up 0.06% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #332 holding.
- Susquehanna Portfolio Strategies first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 4 quarters since.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.